Min‐Huan Wu

949 citations
21 papers · 772 indexed · h-index 14
Topics
Angiogenesis and VEGF in Cancer (4 papers)Cell Adhesion Molecules Research (4 papers)Cytokine Signaling Pathways and Interactions (3 papers)
Partner nations
TaiwanChinaUnited States

In The Last Decade

Min‐Huan Wu

21 papers receiving 766 citations

Peers

Min‐Huan Wu
Comparison fields: 5 of 79
  • Oncology 341
  • Molecular Biology 256
  • Immunology 204
  • Cancer Research 108
  • Physiology 102
Replace Fei Zhu with:
Fei Zhu China
Deepali Kurundkar United States
JiaDe Yu United States
Yeun-Jund Shyy United States
Ane Salvador United States
Yilin Zhao China
Fumitaka Mizoguchi Japan
Wilfried Schgoer Austria
Paul‐Eduard Neagoe Canada
Zhenzhen Wu China
Min‐Huan Wu relative to Fei Zhu China Fei Zhu's profile →
Citations per field
00.5×3.0×
Fei Zhu · 1×
Citations per year

Countries citing papers authored by Min‐Huan Wu

Since Specialization
Citations

This map shows the geographic impact of Min‐Huan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Huan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Huan Wu more than expected).

Fields of papers citing papers by Min‐Huan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min‐Huan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Huan Wu. The network helps show where Min‐Huan Wu may publish in the future.

Co-authorship network of co-authors of Min‐Huan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Huan Wu. A scholar is included among the top collaborators of Min‐Huan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Huan Wu. Min‐Huan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 8
3 4
4 3
5 2
6 17
7 17
8 4
9 19
10 42
11 65
12 14
13 30
14 34
15 1
16 23
17 39
18 53
19 316
20 41

About Min‐Huan Wu

Min‐Huan Wu is a scholar working on Immunology and Allergy, Complementary and alternative medicine and Cancer Research, having authored 21 papers that have together received 772 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Oncology (341 citations), Immunology and Allergy (61 citations) and Immunology (204 citations). Min‐Huan Wu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Henry E. Wiley, Wusi C. Maki, Sam T. Hwang, Chih‐Hsin Tang, Chun‐Hao Tsai, Yi‐Chin Fong, Yuan‐Li Huang, Shih‐Wei Wang, Tieh‐Cheng Fu and Chih‐Chin Hsu. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Scientific Reports and Journal of Applied Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026